Details
Question
- What is the comparative clinical effectiveness cyclophosphamide + bortezomib + dexamethasone (CyBorD) versus bortezomib + melphalan + prednisone (VMP) for newly diagnosed patients with multiple myeloma where there is no intent for stem cell transplantation?
- What is the comparative clinical effectiveness cyclophosphamide + bortezomib + dexamethasone (CyBorD) versus lenalidomide + dexamethasone (RD) for newly diagnosed patients with multiple myeloma where there is no intent for stem cell transplantation?